T 2455/17 vom 26.02.2019
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2019:T245517.20190226
- Datum der Entscheidung
- 26. Februar 2019
- Aktenzeichen
- T 2455/17
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 14161991.6
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Repositionable heart valve
- Name des Antragstellers
- Boston Scientific Scimed, Inc.
- Name des Einsprechenden
- Medtronic CV Luxembourg S.à.r.l./
Medtronic Vascular Galway - Kammer
- 3.2.08
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Schlagwörter
- Grounds for opposition - insufficiency of disclosure (no)
Grounds for opposition - subject-matter extends beyond content of earlier application (no)
Grounds for opposition - added subject-matter (no)
Grounds for opposition - clarity in opposition appeal proceedings
Novelty - (yes)
Inventive step - (yes)
Amendments - allowable (yes)
Amendments - intermediate generalisation
Amendments - added subject-matter (no)
Claims - support in the description (yes) - Orientierungssatz
- -
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent as amended in the following version:
Claims 1-11 of the main request filed as auxiliary request 7a with letter dated 17 January 2019,
Columns 1, 2, 5-26 of the patent specification, and columns 3 and 4 as filed during the oral proceedings on 11/12 September 2017,
Figures 1A-31B of the patent specification.